List of Excipients in API elagolix
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing elagolix
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | CARMINIC ACID | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | MAGNESIUM STEARATE | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | MANNITOL | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | POLYETHYLENE GLYCOL | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | POLYVINYL ALCOHOL | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | POVIDONE | 2029-07-06 |
| AbbVie Inc | ORILISSA | elagolix | 0074-0038 | SODIUM CARBONATE MONOHYDRATE | 2029-07-06 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for elagolix
Excipient focus: CARMINIC ACID
elagolix drug variants containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
elagolix drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
elagolix drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
elagolix drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
elagolix drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
elagolix drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE MONOHYDRATE
elagolix drug variants containing SODIUM CARBONATE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing SODIUM CARBONATE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
elagolix drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
elagolix drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
elagolix drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | elagolix | 0074-0038 |
| >Company | >Ingredient | >NDC |
elagolix drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
